A review of methods for solubility determination in biopharmaceutical drug characterization

References

• Amidon GL, Lennernas H, Shah VP, et al. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12(3):413–420.
   PubMed Web of Science ®Google Scholar
• Alsenz J, Kansy M. High throughput solubility measurement in drug discovery and development. Adv Drug Deliv Rev. 2007;59(7):546–567.
   PubMed Web of Science ®Google Scholar
• Rinaki E, Valsami G, Macheras P. Quantitative biopharmaceutics classification system: the central role of dose/solubility ratio. Pharm Res. 2003;20(12):1917–1925.
   PubMed Web of Science ®Google Scholar
• Di L, Kerns E, Carter G. Drug-like property concepts in pharmaceutical design. Curr Pharm Des. 2009;15(19):2184–2194.
   PubMed Web of Science ®Google Scholar
• Wang J, Urban L. The impact of early ADME profiling on drug discovery and development strategy. Drug Discov. 2004;4:72–96.
   Google Scholar
• Elder D, Holm R. Aqueous solubility: Simple predictive methods (in silico, in vitro and bio-relevant approaches). Int J Pharm. 2013;453(1):3–11.
   PubMedGoogle Scholar
• Baka E, Comer JEA, Takács-Novák K. Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound. J Pharm Biomed Anal. 2008;46(2):335–341.
   PubMed Web of Science ®Google Scholar
• Bhattachar SN, Deschenes LA, Wesley JA. Solubility: it's not just for physical chemists. Drug Discov Today. 2006;11(21–22):1012–1018.
   PubMed Web of Science ®Google Scholar
• (Tony)Tong W-Q. Practical Aspects of Solubility Determination in Pharmaceutical Preformulation In: Augustijns P, Brewster ME, editors. Solvent systems and their selection in pharmaceutics and biopharmaceutics. New York (NY): Springer; 2007. p. 137–149.
   Google Scholar
• Wang Z, Burrell LS, Lambert WJ. Solubility of E2050 at various pH: a case in which apparent solubility is affected by the amount of excess solid. J Pharm Sci. 2002;91(6):1445–1455.
   PubMed Web of Science ®Google Scholar
• Murdande SB, Pikal MJ, Shanker RM, et al. Aqueous solubility of crystalline and amorphous drugs: challenges in measurement. Pharm Dev Technol. 2011;16(3):187–200.
   PubMed Web of Science ®Google Scholar
• Kawakami K, Miyoshi K, Ida Y. Impact of the amount of excess solids on apparent solubility. Pharm Res. 2005;22(9):1537–1543.
   PubMed Web of Science ®Google Scholar
• Comer J, Judge S, Matthews D, et al. The intrinsic aqueous solubility of indomethacin. Admet Dmpk. 2014;2(1):18–32.
   Google Scholar
• Higuchi T, Shih F-M, Kimura T, et al. Solubility determination of barely Aqueous-Soluble organic solids. J Pharm Sci. 1979;68(10):1267–1272.
   PubMed Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 1997;23(1–3):3–25.
   Web of Science ®Google Scholar
• Mora CP, Martínez F. Solubility of naproxen in several organic solvents at different temperatures. Fluid Phase Equilib. 2007;255(1):70–77.
   Web of Science ®Google Scholar
• Etzweiler F, Senn E, Schmidt H. Method for measuring aqueous solubilities of organic compounds. Anal Chem. 1995;67(3):655–658.
   Web of Science ®Google Scholar
• Loftsson T, Hreinsdóttir D, Másson M. Evaluation of cyclodextrin solubilization of drugs. Int J Pharm. 2005;302(1–2):18–28.
   PubMed Web of Science ®Google Scholar
• Buch P, Meyer C, Langguth P. Improvement of the wettability and dissolution of fenofibrate compacts by plasma treatment. Int J Pharm. 2011;416(1):49–54.
   PubMedGoogle Scholar
• U.S. Food and Drug Administration. Guidance for Industry: waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on the Biopharmaceutics. Classification system. [Internet]. [cited 2019 Aug 16]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/waiver-vivo-bioavailability-and-bioequivalence-studies immediate-release-solid-oral-dosage-forms
   Google Scholar
• European Medicines Agency. Evaluation of medicines for human use. Committee for proprietary medicinal products. Note for guidance on the investigation of bioavailability and bioequivalence. [Internet]. [Cited 2019 Aug 16]. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/draft-note-guidance-investigation-bioavailability-bioequivalence_en.pdf
   Google Scholar
• Avdeef A, Fuguet E, Llinàs A, et al. Equilibrium solubility measurement of ionizable drugs – consensus recommendations for improving data quality. Admet DMPK. 2016;4:117–178.
   Google Scholar
• Kawabata Y, Wada K, Nakatani M, et al. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: Basic approaches and practical applications. Int J Pharm. 2011;420(1):1–10.
   PubMed Web of Science ®Google Scholar
• Brittain HG. Spectral methods for the characterization of polymorphs and solvates. J Pharm Sci. 1997;86(4):405–412.
   PubMed Web of Science ®Google Scholar
• Pan L, Ho Q, Tsutsui K, et al. Comparison of chromatographic and spectroscopic methods used to rank compounds for aqueous solubility. J Pharm Sci. 2001;90(4):521–529.
   PubMed Web of Science ®Google Scholar
• Dalvit C, Flocco M, Knapp S, et al. High-throughput NMR-based screening with competition binding experiments. J Am Chem Soc. 2002;124(26):7702–7709.
   PubMed Web of Science ®Google Scholar
• Mohan R, Lorenz H, Myerson AS. Solubility measurement using differential scanning calorimetry. Ind Eng Chem Res. 2002;41(19):4854–4862.
   Web of Science ®Google Scholar
• Glomme A, März J, Dressman JB. Comparison of a miniaturized shake-flask solubility method with automated potentiometric acid/base titrations and calculated solubilities. J Pharm Sci. 2005;94(1):1–16.
   PubMed Web of Science ®Google Scholar
• Bergström CAS, Norinder U, Luthman K, et al. Experimental and computational screening models for prediction of aqueous drug solubility. Pharm Res. 2002;19(2):182–188.
   PubMed Web of Science ®Google Scholar
• Bergström CAS, Luthman K, Artursson P. Accuracy of calculated pH-dependent aqueous drug solubility. Eur J Pharm Sci. 2004;22(5):387–398.
   PubMed Web of Science ®Google Scholar
• Chen X-Q, Venkatesh S. Miniature Device for Aqueous and Non-aqueous Solubility Measurements During Drug Discovery. Pharm Res. 2004;21(10):1758–1761.
   PubMed Web of Science ®Google Scholar
• Dai WG, Pollock-Dove C, Dong LC, et al. Advanced screening assays to rapidly identify solubility-enhancing formulations: High-throughput, miniaturization and automation. Adv Drug Deliv Rev. 2008;60(6):657–672.
   PubMed Web of Science ®Google Scholar
• Tan H, Semin D, Wacker M, et al. An automated screening assay for determination of aqueous equilibrium solubility enabling SPR study during drug lead optimization. JALA - J Assoc Lab Autom. 2005;10(6):364–373.
   Google Scholar
• Bharate SS, Vishwakarma RA. Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery. Bioorganic Med Chem Lett. 2015;25(7):1561–1567.
   PubMed Web of Science ®Google Scholar
• Roy D, Ducher F, Laumain A, et al. Determination of the aqueous solubility of drugs using a convenient 96-well plate-based assay. Drug Dev Ind Pharm. 2001;27(1):107–109.
   PubMed Web of Science ®Google Scholar
• Alsenz J, Meister E, Haenel E. Development of a partially automated solubility screening (PASS) assay for early drug development. J Pharm Sci. 2007;96(7):1748–1762.
   PubMed Web of Science ®Google Scholar
• Wyttenbach N, Alsenz J, Grassmann O. Miniaturized assay for solubility and residual solid screening (SORESOS) in early drug development. Pharm Res. 2007;24(5):888–898.
   PubMed Web of Science ®Google Scholar
• Miller JM, Collman BM, Greene LR, et al. Identifying the stable polymorph early in the drug Discovery–development process. Pharm Dev Technol. 2005;10:291–297.
   PubMed Web of Science ®Google Scholar
• Meylan WM, Howard PH. Atom/fragment contribution method for estimating octanol-water partition coefficients. Perspect Drug Discov Des. 2000;19(1):67–84.
   Google Scholar
• Bernard F, Frank W. Physicochemical parameters as tools in drug discovery and lead optimization In: Bernard T, Van de Waterbeemd H, Gerd F, Richard G, editors. Pharmacokinetic optimization in drug research. Weinheim, Germany: Wiley-VCH; 2001. p. 257–274.
   Google Scholar
• Abraham MH, Le J. The correlation and prediction of the solubility of compounds in water using an amended solvation energy relationship. J Pharm Sci. 1999;88(9):868–880.
   PubMed Web of Science ®Google Scholar
• ACD/Solubility [Internet]. Toronto, Ontario [cited 2019 Mar 20] Available from: https://www.acdlabs.com/products/percepta/predictors.php
   Google Scholar
• Gopi SP, Banik M, Desiraju GR. New cocrystals of hydrochlorothiazide: optimizing solubility and membrane diffusivity. Cryst Growth Des. 2017;17(1):308–316.
   Web of Science ®Google Scholar
• Banerjee R, Bhatt PM, Ravindra NV, et al. Saccharin salts of active pharmaceutical ingredients, their crystal structures, and increased water solubilities. Cryst Growth Des. 2005;5(6):2299–2309.
   Web of Science ®Google Scholar
• Rajput L. Stable crystalline salts of haloperidol: a highly water-soluble mesylate salt. Cryst Growth Des. 2014;14(10):5196–5205.
   Web of Science ®Google Scholar
• da Silva CC, Cirqueira M de L, Martins FT. Lamivudine salts with 1,2-dicarboxylic acids: a new and a rare synthon with double pairing motif fine-tuning their solubility. CrystEngComm. 2013;15(32):6311–6317.
   Web of Science ®Google Scholar
• Jantratid E, Janssen N, Chokshi H, et al. Designing biorelevant dissolution tests for lipid formulations: case example-lipid suspension of RZ-50. Eur J Pharm Biopharm. 2008;69(2):776–785.
   PubMed Web of Science ®Google Scholar
• Chen J, Wang J, Schwab LP, et al. Benzimidazole analogs as potent hypoxia inducible factor inhibitors: synthesis, biological evaluation, and profiling Drug-like properties. Anticancer Res. 2014;34(8):3891–3904.
   PubMed Web of Science ®Google Scholar
• Ruff A, Fiolka T, Kostewicz ES. Prediction of Ketoconazole absorption using an updated in vitro transfer model coupled to physiologically based pharmacokinetic modelling. Eur J Pharm Sci. 2017;100:42–55.
   PubMed Web of Science ®Google Scholar
• Avdeef A. Phosphate precipitates and Water-soluble aggregates in Re-analyzed Solubility-pH data of Twenty-five basic drugs. Admet Dmpk. 2014;2(1):43–55.
   Google Scholar
• Avdeef A. Suggested improvements for measurement of equilibrium Solubility-pH of ionizable drugs. Admet Dmpk. 2015;3(2):84–109.
   Google Scholar
• Völgyi G, Baka E, Box KJ, et al. Study of pH-dependent solubility of organic bases. Revisit of Henderson-Hasselbalch relationship. Anal Chim Acta. 2010;673(1):40–46.
   PubMed Web of Science ®Google Scholar
• Kerns EH, Di L, Carter GT. In vitro solubility assays in drug discovery. Curr Drug Metab. 2008;9(9):879–885.
   PubMed Web of Science ®Google Scholar
• Avdeef A. pH‐metric Solubility. 1. Solubility‐pH Profiles from Bjerrum Plots. Gibbs Buffer and pKa in the solid state. Pharm Pharmacol Commun. 1998;4:165–178.
   Google Scholar
• McFarland JW, Avdeef A, Berger CM, et al. Estimating the water solubilities of crystalline compounds from their chemical structures alone. J Chem Inf Comput Sci. 2001;41(5):1355–1359.
   PubMedGoogle Scholar
• FDA, U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) BP (Guidance 3618FNL) [Internet]. [cited 2019 Feb 26]. Available from: https://www.fda.gov/downloads/Drugs/Guidances/ucm070246.pdf
   Google Scholar
• Valko K, Reynolds DP. High-throughput physicochemical and in vitro ADMET screening. Am J Drug Deliv. 2005;3(2):83–100.
   Google Scholar
• Stuart M, Box K. Chasing equilibrium: measuring the intrinsic solubility of weak acids and bases. Anal Chem. 2005;77(4):983–990.
   PubMed Web of Science ®Google Scholar
• Fornells E, Fuguet E, Mañé M, et al. Effect of vinylpyrrolidone polymers on the solubility and supersaturation of drugs; a study using the Cheqsol method. Eur J Pharm Sci. 2018;117:227–235.
   PubMed Web of Science ®Google Scholar
• Box KJ, Völgyi G, Baka E, et al. Equilibrium versus kinetic measurements of aqueous solubility, and the ability of compounds to supersaturate in solution-a validation study. J Pharm Sci. 2006;95(6):1298–1307.
   PubMed Web of Science ®Google Scholar
• Veith GD, Comstock VM. Apparatus for continuously saturating water with hydrophobic organic chemicals. J Fish Res Bd Can. 1975;32(10):1849–1851.
   Google Scholar
• Guidelines for The Testing of Chemicals, OECD 105, Water Solubility (Column Elution Method-Shake Flask Method), OECD, Paris, France. Organ Econ Coop Dev. 1981. [Internet] [cited 2019 Aug 16]. Available from: http://www.oecd.org/chemicalsafety/risk-assessment/1948185.pdf
   Google Scholar
• Di L, Fish PV, Mano T. Bridging solubility between drug discovery and development. Drug Discov Today. 2012;17(9–10):486–495.
   PubMed Web of Science ®Google Scholar